Terns Pharmaceuticals (TERN) EPS (Basic) (2020 - 2023)
Historic EPS (Basic) for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to -$0.29.
- Terns Pharmaceuticals' EPS (Basic) fell 7058.82% to -$0.29 in Q4 2023 from the same period last year, while for Dec 2023 it was -$1.27, marking a year-over-year increase of 2573.1%. This contributed to the annual value of -$1.12 for FY2024, which is 1181.1% up from last year.
- According to the latest figures from Q4 2023, Terns Pharmaceuticals' EPS (Basic) is -$0.29, which was down 7058.82% from -$0.42 recorded in Q3 2023.
- Terns Pharmaceuticals' EPS (Basic)'s 5-year high stood at $8.45 during Q4 2020, with a 5-year trough of -$41.69 in Q1 2020.
- For the 4-year period, Terns Pharmaceuticals' EPS (Basic) averaged around -$6.84, with its median value being -$0.46 (2022).
- Examining YoY changes over the last 5 years, Terns Pharmaceuticals' EPS (Basic) showed a top increase of 9875.57% in 2021 and a maximum decrease of 10674.56% in 2021.
- Terns Pharmaceuticals' EPS (Basic) (Quarter) stood at $8.45 in 2020, then plummeted by 106.75% to -$0.57 in 2021, then skyrocketed by 70.18% to -$0.17 in 2022, then tumbled by 70.59% to -$0.29 in 2023.
- Its last three reported values are -$0.29 in Q4 2023, -$0.42 for Q3 2023, and -$0.25 during Q2 2023.